AI Article Synopsis

  • This study examines the use of adeno-associated virus5 (AAV5) to deliver the genes for decorin (DCN) and pigment epithelium-derived factor (PEDF) to treat corneal fibrosis and neovascularization (CNV) caused by chemical trauma in rabbits.
  • Results showed that this gene therapy significantly decreased levels of corneal fibrosis and CNV compared to untreated eyes, with improved histological outcomes and increased induction of apoptotic cell death in neovessels.
  • The therapy was found to be tolerable with no significant toxicity, suggesting potential for further research and application in treating ocular trauma-related vision impairments.

Article Abstract

Purpose: Corneal fibrosis and neovascularization (CNV) after ocular trauma impairs vision. This study tested therapeutic potential of tissue-targeted adeno-associated virus5 (AAV5) mediated decorin (DCN) and pigment epithelium-derived factor (PEDF) combination genes in vivo.

Methods: Corneal fibrosis and CNV were induced in New Zealand White rabbits via chemical trauma. Gene therapy in stroma was delivered 30-min after chemical-trauma via topical AAV5-DCN and AAV5-PEDF application using a cloning cylinder. Clinical eye examinations and multimodal imaging in live rabbits were performed periodically and corneal tissues were collected 9-day and 15-day post euthanasia. Histological, cellular, and molecular and apoptosis assays were used for efficacy, tolerability, and mechanistic studies.

Results: The AAV5-DCN and AAV5-PEDF combination gene therapy significantly reduced corneal fibrosis (p < 0.01 or p < 0.001) and CNV (p < 0.001) in therapy-given (chemical-trauma and AAV5-DCN + AAV5-PEDF) rabbit eyes compared to the no-therapy given eyes (chemical-trauma and AAV5-naked vector). Histopathological analyses demonstrated significantly reduced fibrotic α-smooth muscle actin and endothelial lectin expression in therapy-given corneas compared to no-therapy corneas on day-9 (p < 0.001) and day-15 (p < 0.001). Further, therapy-given corneas showed significantly increased Fas-ligand mRNA levels (p < 0.001) and apoptotic cell death in neovessels (p < 0.001) compared to no-therapy corneas. AAV5 delivered 2.69 × 10 copies of DCN and 2.31 × 10 copies of PEDF genes per μg of DNA. AAV5 vector and delivered DCN and PEDF genes found tolerable to the rabbit eyes and caused no significant toxicity to the cornea.

Conclusion: The combination AAV5-DCN and AAV5-PEDF topical gene therapy effectively reduces corneal fibrosis and CNV with high tolerability in vivo in rabbits. Additional studies are warranted.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtos.2024.01.001DOI Listing

Publication Analysis

Top Keywords

corneal fibrosis
16
aav5-dcn aav5-pedf
12
gene therapy
12
aav5-pedf combination
8
combination gene
8
corneal
5
tissue-targeted localized
4
localized aav5-dcn
4
therapy abrogates
4
abrogates corneal
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!